Metabolic derangements with olanzapine and risperidone in schizophrenia spectrum and other psychotic disorders: A 24-week prospective study

BACKGROUND AND AIMS: Schizophrenia spectrum and other psychotic disorders are common disorders often requiring long-term treatment with atypical antipsychotics, which might cause metabolic dysfunctions. We aimed to study the metabolic dysfunctions with olanzapine and risperidone in patients with sch...

Descripción completa

Detalles Bibliográficos
Autores principales: Rikhari, Praveen, Kumar, Ashutosh, Agrawal, Prabhat, Kumar, Harendra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254779/
https://www.ncbi.nlm.nih.gov/pubmed/35800481
http://dx.doi.org/10.4103/jfmpc.jfmpc_2161_21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254779/
https://www.ncbi.nlm.nih.gov/pubmed/35800481
http://dx.doi.org/10.4103/jfmpc.jfmpc_2161_21

Ejemplares similares